Grace M. Niemiro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Grace M. Niemiro has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Charles Richard Pedlar
School of Sport, Health and Applied Science, St Mary’s University Twickenham, Twickenham, UK
23 shared publications - Daniel P. O'Connor
Department of Health and Human Performance, University of Houston, Houston, Texas
23 shared publications - Douglass M. Diak
Immunology and Virology Laboratory, NASA-Johnson Space Center (NASA-JSC), Aegis Aerospace, United States
23 shared publications - Emmanuel Katsanis
Department of Pediatrics, University of Arizona
23 shared publications - Forrest L. Baker
School of Nutritional Sciences and Wellness, University of Arizona, Tucson, AZ
23 shared publications - Helena Batatinha
School of Nutritional Sciences and Wellness, University of Arizona, Tucson, AZ
23 shared publications
Latest Publications
- Open Access
- 9 October 2026
- Published by Elsevier in Current Developments in Nutrition
- Vol. 10 (11)
Combination of Oral Nutritional Supplements and Dietary Counseling Is More Effective than Dietary Counseling Alone in Improving Growth Indicators among Undernourished United States Children: A Randomized Controlled Clinical Trial
- 9 October 2026
- Published by Elsevier in Current Developments in Nutrition
- Vol. 10 (11)
Open AccessCombination of Oral Nutritional Supplements and Dietary Counseling Is More Effective than Dietary Counseling Alone in Improving Growth Indicators among Undernourished United States Children: A Randomized Controlled Clinical Trial
- Open Access
Key Nutrient Intakes at Risk Among US Children in the National Health and Nutrition Examination Survey (NHANES) 2015–2016 Stratified by Age and Gender
Background/Objective: Inadequate nutrient intake in childhood can have lasting detrimental developmental and health outcomes. The objective of this study was to identify key nutrient intake gaps among US children. Method: Using the National Health and Nutrition Examination Survey 2015–2016 data, we compared nutrient intakes against dietary reference intakes (DRIs). Participants were grouped by age (in years): 0–0.5, 0.6–1, 1–4, 5–8, 9–14, and 15–19. Gender differences were assessed in the two older groups. Results: Linoleic acid, linolenic acid, vitamin D, and choline were the most consumed at lesser than DRIs in all age groups. Additionally, dietary fiber, vitamin A, vitamin E, vitamin K, folate, iron, and calcium were consumed at lesser than DRIs in 1–19 year olds. They also had an inadequate intake of docosahexaenoic acid (DHA). Children with nutrient intake gaps increased from infancy and toddlerhood to school-age period, with the inflection point at 5–8 years of age when parents have limited control on children’s nutrient intake. Above 9 years of age, females had greater nutrient intake gaps than males. Females in the 15–19-year-old segment especially had higher nutrient intake gaps (p < 0.05) for vitamin D, thiamin, riboflavin, vitamin B12, folate, iron, calcium, magnesium, phosphorus, and potassium compared to males. Selected laboratory biomarkers were used to verify the nutrient intake data. Conclusions: Key nutrient intake gaps were identified among different age groups of children in the US, which may have implications for future dietary interventions and target food formulations to help narrow these gaps.
Open AccessKey Nutrient Intakes at Risk Among US Children in the National Health and Nutrition Examination Survey (NHANES) 2015–2016 Stratified by Age and Gender
Background/Objective: Inadequate nutrient intake in childhood can have lasting detrimental developmental and health outcomes. The objective of this study was to identify key nutrient intake gaps among US children. Method: Using the National Health and Nutrition Examination Survey 2015–2016 data, we compared nutrient intakes against dietary reference intakes (DRIs). Participants were grouped by age (in years): 0–0.5, 0.6–1, 1–4, 5–8, 9–14, and 15–19. Gender differences were assessed in the two older groups. Results: Linoleic acid, linolenic acid, vitamin D, and choline were the most consumed at lesser than DRIs in all age groups. Additionally, dietary fiber, vitamin A, vitamin E, vitamin K, folate, iron, and calcium were consumed at lesser than DRIs in 1–19 year olds. They also had an inadequate intake of docosahexaenoic acid (DHA). Children with nutrient intake gaps increased from infancy and toddlerhood to school-age period, with the inflection point at 5–8 years of age when parents have limited control on children’s nutrient intake. Above 9 years of age, females had greater nutrient intake gaps than males. Females in the 15–19-year-old segment especially had higher nutrient intake gaps (p < 0.05) for vitamin D, thiamin, riboflavin, vitamin B12, folate, iron, calcium, magnesium, phosphorus, and potassium compared to males. Selected laboratory biomarkers were used to verify the nutrient intake data. Conclusions: Key nutrient intake gaps were identified among different age groups of children in the US, which may have implications for future dietary interventions and target food formulations to help narrow these gaps.
- Open Access
- 13 May 2024
- Published by American Association for Cancer Research (AACR)
Data from Exercise-induced β2-adrenergic Receptor Activation Enhances the Antileukemic Activity of Expanded γδ T-Cells via DNAM-1 Upregulation and PVR/Nectin-2 Recognition
Exercise mobilizes cytotoxic lymphocytes to blood which may allow superior cell products to be harvested and manufactured for cancer therapy. Gamma-Delta (γδ) T-cells have shown promise for treating solid tumors, but there is a need to increase their potency against hematologic malignancies. Here, we show that human γδ T-cells mobilized to blood in response to just 20 minutes of graded exercise have surface phenotypes and transcriptomic profiles associated with cytotoxicity, adhesion, migration, and cytokine signaling. Following 14 days ex vivo expansion with zoledronic acid and IL2, exercise mobilized γδ T-cells had surface phenotypes and transcriptomic profiles associated with enhanced effector functions and demonstrated superior cytotoxic activity against multiple hematologic tumors in vitro and in vivo in leukemia-bearing xenogeneic mice. Infusing humans with the β1+β2-agonist isoproterenol and administering β1 or β1+β2 antagonists prior to exercise revealed these effects to be β2-adrenergic receptor (AR) dependent. Antibody blocking of DNAM-1 on expanded γδ T-cells, as well as the DNAM-1 ligands PVR and Nectin-2 on leukemic targets, abolished the enhanced antileukemic effects of exercise. These findings provide a mechanistic link between exercise, β2-AR activation, and the manufacture of superior γδ T-cell products for adoptive cell therapy against hematologic malignancies.Significance:Exercise mobilizes effector γδ T-cells to blood via β2-adrenergic signaling which allows for generation of a potent expanded γδ T-cell product that is highly cytotoxic against hematologic malignancies.
- 13 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessData from Exercise-induced β2-adrenergic Receptor Activation Enhances the Antileukemic Activity of Expanded γδ T-Cells via DNAM-1 Upregulation and PVR/Nectin-2 Recognition
Exercise mobilizes cytotoxic lymphocytes to blood which may allow superior cell products to be harvested and manufactured for cancer therapy. Gamma-Delta (γδ) T-cells have shown promise for treating solid tumors, but there is a need to increase their potency against hematologic malignancies. Here, we show that human γδ T-cells mobilized to blood in response to just 20 minutes of graded exercise have surface phenotypes and transcriptomic profiles associated with cytotoxicity, adhesion, migration, and cytokine signaling. Following 14 days ex vivo expansion with zoledronic acid and IL2, exercise mobilized γδ T-cells had surface phenotypes and transcriptomic profiles associated with enhanced effector functions and demonstrated superior cytotoxic activity against multiple hematologic tumors in vitro and in vivo in leukemia-bearing xenogeneic mice. Infusing humans with the β1+β2-agonist isoproterenol and administering β1 or β1+β2 antagonists prior to exercise revealed these effects to be β2-adrenergic receptor (AR) dependent. Antibody blocking of DNAM-1 on expanded γδ T-cells, as well as the DNAM-1 ligands PVR and Nectin-2 on leukemic targets, abolished the enhanced antileukemic effects of exercise. These findings provide a mechanistic link between exercise, β2-AR activation, and the manufacture of superior γδ T-cell products for adoptive cell therapy against hematologic malignancies.Significance:Exercise mobilizes effector γδ T-cells to blood via β2-adrenergic signaling which allows for generation of a potent expanded γδ T-cell product that is highly cytotoxic against hematologic malignancies.
- Open Access
- 13 May 2024
- Published by American Association for Cancer Research (AACR)
FIGURE 3 from Exercise-induced β2-adrenergic Receptor Activation Enhances the Antileukemic Activity of Expanded γδ T-Cells via DNAM-1 Upregulation and PVR/Nectin-2 Recognition
Blockade of β2-AR blunts the mobilization and expansion of Vγ9Vδ2+ T-cells. A, The physiologic effects of a placebo, β1-AR antagonist (10 mg bisoprolol), or a nonselective β1+β2 antagonist (80 mg, nadolol) on VO2 (mL/minute), systolic blood pressure (mmHg), HR (bpm), epinephrine (ng/mL), and norepinephrine (ng/mL) during the last minutes of acute exercise (n = 9). The effects of a placebo, β1-AR antagonist, or a nonselective β1+β2 antagonist on the total number of Vγ9Vδ2+ T-cells mobilized with exercise (B) and the ex vivo expansion of Vγ9Vδ2+ T-cells after 14 days with ZOL+IL2 (n = 9; C). Data are represented as mean ± SEM; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 by repeated measures one-way ANOVA with Bonferroni post hoc test.
- 13 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFIGURE 3 from Exercise-induced β2-adrenergic Receptor Activation Enhances the Antileukemic Activity of Expanded γδ T-Cells via DNAM-1 Upregulation and PVR/Nectin-2 Recognition
Blockade of β2-AR blunts the mobilization and expansion of Vγ9Vδ2+ T-cells. A, The physiologic effects of a placebo, β1-AR antagonist (10 mg bisoprolol), or a nonselective β1+β2 antagonist (80 mg, nadolol) on VO2 (mL/minute), systolic blood pressure (mmHg), HR (bpm), epinephrine (ng/mL), and norepinephrine (ng/mL) during the last minutes of acute exercise (n = 9). The effects of a placebo, β1-AR antagonist, or a nonselective β1+β2 antagonist on the total number of Vγ9Vδ2+ T-cells mobilized with exercise (B) and the ex vivo expansion of Vγ9Vδ2+ T-cells after 14 days with ZOL+IL2 (n = 9; C). Data are represented as mean ± SEM; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 by repeated measures one-way ANOVA with Bonferroni post hoc test.
- Open Access
- 13 May 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Exercise-induced β2-adrenergic Receptor Activation Enhances the Antileukemic Activity of Expanded γδ T-Cells via DNAM-1 Upregulation and PVR/Nectin-2 Recognition
Supplemental Figure S1: The percentage or MFI of activating, inhibitory, and chemokine receptors among Vd2+ and Vd1+ T-cells before and during acute exercise
- 13 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Exercise-induced β2-adrenergic Receptor Activation Enhances the Antileukemic Activity of Expanded γδ T-Cells via DNAM-1 Upregulation and PVR/Nectin-2 Recognition
Supplemental Figure S1: The percentage or MFI of activating, inhibitory, and chemokine receptors among Vd2+ and Vd1+ T-cells before and during acute exercise
- Open Access
- 13 May 2024
- Published by American Association for Cancer Research (AACR)
TABLE 1 from Exercise-induced β2-adrenergic Receptor Activation Enhances the Antileukemic Activity of Expanded γδ T-Cells via DNAM-1 Upregulation and PVR/Nectin-2 Recognition
The effect of acute exercise on lymphocyte subsets
- 13 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTABLE 1 from Exercise-induced β2-adrenergic Receptor Activation Enhances the Antileukemic Activity of Expanded γδ T-Cells via DNAM-1 Upregulation and PVR/Nectin-2 Recognition
The effect of acute exercise on lymphocyte subsets
- Open Access
- 13 May 2024
- Published by American Association for Cancer Research (AACR)
Data from Exercise-induced β2-adrenergic Receptor Activation Enhances the Antileukemic Activity of Expanded γδ T-Cells via DNAM-1 Upregulation and PVR/Nectin-2 Recognition
Exercise mobilizes cytotoxic lymphocytes to blood which may allow superior cell products to be harvested and manufactured for cancer therapy. Gamma-Delta (γδ) T-cells have shown promise for treating solid tumors, but there is a need to increase their potency against hematologic malignancies. Here, we show that human γδ T-cells mobilized to blood in response to just 20 minutes of graded exercise have surface phenotypes and transcriptomic profiles associated with cytotoxicity, adhesion, migration, and cytokine signaling. Following 14 days ex vivo expansion with zoledronic acid and IL2, exercise mobilized γδ T-cells had surface phenotypes and transcriptomic profiles associated with enhanced effector functions and demonstrated superior cytotoxic activity against multiple hematologic tumors in vitro and in vivo in leukemia-bearing xenogeneic mice. Infusing humans with the β1+β2-agonist isoproterenol and administering β1 or β1+β2 antagonists prior to exercise revealed these effects to be β2-adrenergic receptor (AR) dependent. Antibody blocking of DNAM-1 on expanded γδ T-cells, as well as the DNAM-1 ligands PVR and Nectin-2 on leukemic targets, abolished the enhanced antileukemic effects of exercise. These findings provide a mechanistic link between exercise, β2-AR activation, and the manufacture of superior γδ T-cell products for adoptive cell therapy against hematologic malignancies.Significance:Exercise mobilizes effector γδ T-cells to blood via β2-adrenergic signaling which allows for generation of a potent expanded γδ T-cell product that is highly cytotoxic against hematologic malignancies.
- 13 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessData from Exercise-induced β2-adrenergic Receptor Activation Enhances the Antileukemic Activity of Expanded γδ T-Cells via DNAM-1 Upregulation and PVR/Nectin-2 Recognition
Exercise mobilizes cytotoxic lymphocytes to blood which may allow superior cell products to be harvested and manufactured for cancer therapy. Gamma-Delta (γδ) T-cells have shown promise for treating solid tumors, but there is a need to increase their potency against hematologic malignancies. Here, we show that human γδ T-cells mobilized to blood in response to just 20 minutes of graded exercise have surface phenotypes and transcriptomic profiles associated with cytotoxicity, adhesion, migration, and cytokine signaling. Following 14 days ex vivo expansion with zoledronic acid and IL2, exercise mobilized γδ T-cells had surface phenotypes and transcriptomic profiles associated with enhanced effector functions and demonstrated superior cytotoxic activity against multiple hematologic tumors in vitro and in vivo in leukemia-bearing xenogeneic mice. Infusing humans with the β1+β2-agonist isoproterenol and administering β1 or β1+β2 antagonists prior to exercise revealed these effects to be β2-adrenergic receptor (AR) dependent. Antibody blocking of DNAM-1 on expanded γδ T-cells, as well as the DNAM-1 ligands PVR and Nectin-2 on leukemic targets, abolished the enhanced antileukemic effects of exercise. These findings provide a mechanistic link between exercise, β2-AR activation, and the manufacture of superior γδ T-cell products for adoptive cell therapy against hematologic malignancies.Significance:Exercise mobilizes effector γδ T-cells to blood via β2-adrenergic signaling which allows for generation of a potent expanded γδ T-cell product that is highly cytotoxic against hematologic malignancies.
- Open Access
- 13 May 2024
- Published by American Association for Cancer Research (AACR)
FIGURE 3 from Exercise-induced β2-adrenergic Receptor Activation Enhances the Antileukemic Activity of Expanded γδ T-Cells via DNAM-1 Upregulation and PVR/Nectin-2 Recognition
Blockade of β2-AR blunts the mobilization and expansion of Vγ9Vδ2+ T-cells. A, The physiologic effects of a placebo, β1-AR antagonist (10 mg bisoprolol), or a nonselective β1+β2 antagonist (80 mg, nadolol) on VO2 (mL/minute), systolic blood pressure (mmHg), HR (bpm), epinephrine (ng/mL), and norepinephrine (ng/mL) during the last minutes of acute exercise (n = 9). The effects of a placebo, β1-AR antagonist, or a nonselective β1+β2 antagonist on the total number of Vγ9Vδ2+ T-cells mobilized with exercise (B) and the ex vivo expansion of Vγ9Vδ2+ T-cells after 14 days with ZOL+IL2 (n = 9; C). Data are represented as mean ± SEM; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 by repeated measures one-way ANOVA with Bonferroni post hoc test.
- 13 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFIGURE 3 from Exercise-induced β2-adrenergic Receptor Activation Enhances the Antileukemic Activity of Expanded γδ T-Cells via DNAM-1 Upregulation and PVR/Nectin-2 Recognition
Blockade of β2-AR blunts the mobilization and expansion of Vγ9Vδ2+ T-cells. A, The physiologic effects of a placebo, β1-AR antagonist (10 mg bisoprolol), or a nonselective β1+β2 antagonist (80 mg, nadolol) on VO2 (mL/minute), systolic blood pressure (mmHg), HR (bpm), epinephrine (ng/mL), and norepinephrine (ng/mL) during the last minutes of acute exercise (n = 9). The effects of a placebo, β1-AR antagonist, or a nonselective β1+β2 antagonist on the total number of Vγ9Vδ2+ T-cells mobilized with exercise (B) and the ex vivo expansion of Vγ9Vδ2+ T-cells after 14 days with ZOL+IL2 (n = 9; C). Data are represented as mean ± SEM; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 by repeated measures one-way ANOVA with Bonferroni post hoc test.
- Open Access
- 13 May 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Exercise-induced β2-adrenergic Receptor Activation Enhances the Antileukemic Activity of Expanded γδ T-Cells via DNAM-1 Upregulation and PVR/Nectin-2 Recognition
Supplemental Figure S2: The specific lysis of K562 cells by expanded Vγ9Vδ2+ T-cells with respective blocking of TCR-γδ or CMA.
- 13 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Exercise-induced β2-adrenergic Receptor Activation Enhances the Antileukemic Activity of Expanded γδ T-Cells via DNAM-1 Upregulation and PVR/Nectin-2 Recognition
Supplemental Figure S2: The specific lysis of K562 cells by expanded Vγ9Vδ2+ T-cells with respective blocking of TCR-γδ or CMA.
- Open Access
- 13 May 2024
- Published by American Association for Cancer Research (AACR)
FIGURE 4 from Exercise-induced β2-adrenergic Receptor Activation Enhances the Antileukemic Activity of Expanded γδ T-Cells via DNAM-1 Upregulation and PVR/Nectin-2 Recognition
ISO infusion enhances the antileukemic activity of ex vivo expanded Vγ9Vδ2+ T-cells in vitro and in vivo. A, Schematic of the experimental design for in vitro and in vivo experiments. B, The total number (1 × 106) of Vγ9Vδ2+ cells isolated before (REST) and during the final 5 minutes of ISO infusion at day 0, and the total number of Vγ9Vδ2+ T-cells generated in the expanded cell products after stimulation with ZOL+IL2 for 14 days. The number of Vγ9Vδ2+ cells generated at day 14 relative to the number of γδ cells in the PBMC fractions at day 0. The cellular composition of the expanded Vγ9Vδ2+ T-cell products at day 14. The proportions of naïve (N), CM, EM, and CD45RA+ EMRA cells among Vγ9Vδ2+ T-cells after 14 days of expansion (n = 7). C, The in vitro anti-tumor activity of ex vivo expanded Vγ9Vδ2+ T-cells against K562, Daudi, and U266 cells via flow cytometry–based assays. Significance indicated by ** (P < 0.01) and *** (P < 0.001). D, To determine the in vivo GvL effect of ISO expanded Vγ9Vδ2+, NSG-IL15 mice were injected with REST or ISO expanded Vγ9Vδ2+ (10 × 106) and challenged with 1 × 106 luciferase tagged human chronic myeloid leukemia cells (K562-luc). A subset of mice in each group were also provided weekly injections of ZOL (REST+ZOL; ISO+ZOL; VEHICLE +ZOL). The BLI (photons/second) scores, TFS, change in BW, and probability of survival after injection of expanded Vγ9Vδ2+ T-cells with or without ZOL sensitization (n = 7–8/group). BLI significant difference from EX+ZOL and EX conditions indicated by * and #, respectively (all conditions were significantly different from vehicle controls). TFS, BW, and OS significant difference from vehicle controls were indicated by * (TFS; EX, EX+ZOL, and REST+ZOL significance indicated by a single marker). E, Representative bioluminescence images of leukemia-bearing mice that received (from left to right) vehicle, vehicle + ZOL, REST expanded Vγ9Vδ2+ T-cells, REST expanded Vγ9Vδ2+ T-cells + ZOL, ISO expanded Vγ9Vδ2+ T-cells, and ISO expanded Vγ9Vδ2+ T-cells + ZOL. BLI intensity on a scale from low (purple) to high (red). Data are represented as mean ± SEM; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 by Students two-tailed paired t test (B); Repeated measures two-way ANOVA or LMM with Bonferroni post hoc test (C–D); log-rank (Mantel–Cox) test (D).
- 13 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFIGURE 4 from Exercise-induced β2-adrenergic Receptor Activation Enhances the Antileukemic Activity of Expanded γδ T-Cells via DNAM-1 Upregulation and PVR/Nectin-2 Recognition
ISO infusion enhances the antileukemic activity of ex vivo expanded Vγ9Vδ2+ T-cells in vitro and in vivo. A, Schematic of the experimental design for in vitro and in vivo experiments. B, The total number (1 × 106) of Vγ9Vδ2+ cells isolated before (REST) and during the final 5 minutes of ISO infusion at day 0, and the total number of Vγ9Vδ2+ T-cells generated in the expanded cell products after stimulation with ZOL+IL2 for 14 days. The number of Vγ9Vδ2+ cells generated at day 14 relative to the number of γδ cells in the PBMC fractions at day 0. The cellular composition of the expanded Vγ9Vδ2+ T-cell products at day 14. The proportions of naïve (N), CM, EM, and CD45RA+ EMRA cells among Vγ9Vδ2+ T-cells after 14 days of expansion (n = 7). C, The in vitro anti-tumor activity of ex vivo expanded Vγ9Vδ2+ T-cells against K562, Daudi, and U266 cells via flow cytometry–based assays. Significance indicated by ** (P < 0.01) and *** (P < 0.001). D, To determine the in vivo GvL effect of ISO expanded Vγ9Vδ2+, NSG-IL15 mice were injected with REST or ISO expanded Vγ9Vδ2+ (10 × 106) and challenged with 1 × 106 luciferase tagged human chronic myeloid leukemia cells (K562-luc). A subset of mice in each group were also provided weekly injections of ZOL (REST+ZOL; ISO+ZOL; VEHICLE +ZOL). The BLI (photons/second) scores, TFS, change in BW, and probability of survival after injection of expanded Vγ9Vδ2+ T-cells with or without ZOL sensitization (n = 7–8/group). BLI significant difference from EX+ZOL and EX conditions indicated by * and #, respectively (all conditions were significantly different from vehicle controls). TFS, BW, and OS significant difference from vehicle controls were indicated by * (TFS; EX, EX+ZOL, and REST+ZOL significance indicated by a single marker). E, Representative bioluminescence images of leukemia-bearing mice that received (from left to right) vehicle, vehicle + ZOL, REST expanded Vγ9Vδ2+ T-cells, REST expanded Vγ9Vδ2+ T-cells + ZOL, ISO expanded Vγ9Vδ2+ T-cells, and ISO expanded Vγ9Vδ2+ T-cells + ZOL. BLI intensity on a scale from low (purple) to high (red). Data are represented as mean ± SEM; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 by Students two-tailed paired t test (B); Repeated measures two-way ANOVA or LMM with Bonferroni post hoc test (C–D); log-rank (Mantel–Cox) test (D).